USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.
Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, Legrave N, Koenis DS, Koifman G, Sugimoto Y, Llorian Sopena M, MacRae J, Nye E, Howell M, Snijders AP, Prachalias A, Zen Y, Sarker D, Behrens A.
Nelson JK, et al. Among authors: snijders ap.
Nat Commun. 2022 Apr 19;13(1):2070. doi: 10.1038/s41467-022-29684-9.
Nat Commun. 2022.
PMID: 35440539
Free PMC article.